📊 Score Breakdown
Offering Ability
40
Cash Runway
10
Float Risk
45
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
7%
🔄 Reverse Split
15%
• 52-week low $0.93 has breached $1
💹 Market Data
Market Cap$28.43M
Shares Outstanding15.28M
Float6.43M
Cash$510.8K
Debt$91.2K
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest412
Days to Cover1.0
% of Float0.0%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Mar 31, 2026
xbrl
XBRL WARRANT
Dec 31, 2018
4
INSIDER TRANSACTION
Apr 03, 2026
4
INSIDER TRANSACTION
Apr 03, 2026
4
INSIDER TRANSACTION
Apr 03, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CDIX
📊 CDIX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CDIX Signal Convergence & Dark Pool Activity — StonkWhisper
📄 CDIX Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.